Browsing Tag

#Trethera

Trethera Receives Grant from National Institute of Allergy and Infectious Diseases…

Eli Pacheco Jun 28, 2023 0

LOS ANGELES, June 27, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the…

Health

Trethera Receives $2 Million National Cancer Institute Grant for Advancement of…

Eli Pacheco May 30, 2023 0

LOS ANGELES, May 30, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide…

Health

Trethera Announces Poster Presentation at the Americas Committee for Treatment and…

Eli Pacheco Jan 24, 2023 0

LOS ANGELES, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide…

Health

Trethera Announces FDA Orphan Drug Designation Granted to TRE-515 in the Treatment of…

Eli Pacheco Aug 30, 2022 0

LOS ANGELES, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the…

Health

Trethera Announces FDA Orphan Drug Designation Granted to TRE-515 for the Treatment…

Eli Pacheco Aug 9, 2022 0

LOS ANGELES, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide…

Health

Trethera Phase 1 Solid Tumors Trial Dose Escalates To Fourth Cohort After Safety…

Eli Pacheco Jun 2, 2022 0

LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide…